Mark F. Prummel

9.1k total citations · 3 hit papers
77 papers, 6.0k citations indexed

About

Mark F. Prummel is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Ophthalmology. According to data from OpenAlex, Mark F. Prummel has authored 77 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 47 papers in Pathology and Forensic Medicine and 30 papers in Ophthalmology. Recurrent topics in Mark F. Prummel's work include Ophthalmology and Eye Disorders (46 papers), Pituitary Gland Disorders and Treatments (31 papers) and Glaucoma and retinal disorders (25 papers). Mark F. Prummel is often cited by papers focused on Ophthalmology and Eye Disorders (46 papers), Pituitary Gland Disorders and Treatments (31 papers) and Glaucoma and retinal disorders (25 papers). Mark F. Prummel collaborates with scholars based in Netherlands, United States and Germany. Mark F. Prummel's co-authors include Wilmar M. Wiersinga, Maarten P. Mourits, Leo Koornneef, Martin N. Gerding, Arie Berghout, Caroline B. Terwee, Iris M.M.J. Wakelkamp, Friedo W. Dekker, R. van der Gaag and Onno Bakker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Mark F. Prummel

75 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy

1997 732 citations Maarten P. Mourits, Mark F. Prummel et al. Clinical Endocrinology profile →
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

1989 519 citations Maarten P. Mourits, Leo Koornneef et al. British Journal of Ophthalmology profile →
Selenium and the Course of Mild Graves' Orbitopathy

2011 386 citations Mark F. Prummel, Maarten P. Mourits et al. profile →

Peers

Mark F. Prummel

PFM

EDM

OPHTH

NEURO

PPCH

Mario Salvi Italy

Marco Nardi Italy

Petros Perros United Kingdom

Vahab Fatourechi United States

Giuseppe Barbesino United States

Luca Manetti Italy

Willem A. Dik Netherlands

Endre V. Nagy Hungary

Ilan Shimon Israel

Beata Kos‐Kudła Poland

Mario Salvi Italy

Mark F. Prummel

3.6k ×0.8

PFM

3.4k ×0.9

EDM

1.3k ×0.8

OPHTH

1.1k ×0.9

NEURO

369 ×0.6

PPCH

Citations per year, relative to Mark F. Prummel Mark F. Prummel (= 1×) peers Mario Salvi

Countries citing papers authored by Mark F. Prummel

Since Specialization

Citations

This map shows the geographic impact of Mark F. Prummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. Prummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. Prummel more than expected).

Fields of papers citing papers by Mark F. Prummel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark F. Prummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. Prummel. The network helps show where Mark F. Prummel may publish in the future.

Co-authorship network of co-authors of Mark F. Prummel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark F. Prummel. A scholar is included among the top collaborators of Mark F. Prummel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark F. Prummel. Mark F. Prummel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baldeschi, Lelio, et al.. (2007). Reactivation of Graves’ Orbitopathy after Rehabilitative Orbital Decompression. Ophthalmology. 114(7). 1395–1402. 51 indexed citations

Endert, Erik, et al.. (2006). Establishment of reference values for endocrine tests--part V: acromegaly.. PubMed. 64(7). 230–5. 9 indexed citations

Strieder, Thea G. A., et al.. (2006). A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance?. Autoimmunity. 39(2). 93–98. 9 indexed citations

Prummel, Mark F. & Wilmar M. Wiersinga. (2005). Thyroid peroxidase autoantibodies in euthyroid subjects. Best Practice & Research Clinical Endocrinology & Metabolism. 19(1). 1–15. 138 indexed citations

Baldeschi, Lelio, et al.. (2005). The Removal of the Deep Lateral Wall in Orbital Decompression: Its Contribution to Exophthalmos Reduction and Influence on Consecutive Diplopia. American Journal of Ophthalmology. 140(4). 642.e1–642.e8. 76 indexed citations

Strieder, Thea G. A., Mark F. Prummel, Jan G.P. Tijssen, J. F. Brosschot, & Wilmar M. Wiersinga. (2004). Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women. Brain Behavior and Immunity. 19(3). 203–206. 18 indexed citations

Brokken, Leon J. S., Wilmar M. Wiersinga, & Mark F. Prummel. (2003). Thyrotropin Receptor Autoantibodies Are Associated with Continued Thyrotropin Suppression in Treated Euthyroid Graves’ Disease Patients. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4135–4138. 21 indexed citations

Wiersinga, Wilmar M. & Mark F. Prummel. (2002). Graves’ ophthalmopathy: a rational approach to treatment. Trends in Endocrinology and Metabolism. 13(7). 280–287. 56 indexed citations

Wiersinga, Wilmar M. & Mark F. Prummel. (2000). AN EVIDENCE-BASED APPROACH TO THE TREATMENT OF GRAVES' OPHTHALMOPATHY. Endocrinology and Metabolism Clinics of North America. 29(2). 297–319. 30 indexed citations

10.

Gerding, Martin N., Mark F. Prummel, & Wilmar M. Wiersinga. (2000). Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Clinical Endocrinology. 52(5). 641–646. 47 indexed citations

11.

Gerding, Martin N., Friso M. van der Zant, Eric A. van Royen, et al.. (1999). Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy. Clinical Endocrinology. 50(3). 373–379. 55 indexed citations

12.

Terwee, Caroline B., Martin N. Gerding, Friedo W. Dekker, Mark F. Prummel, & Wilmar M. Wiersinga. (1998). Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. British Journal of Ophthalmology. 82(7). 773–779. 217 indexed citations

13.

Gerding, Martin N., Caroline B. Terwee, Friedo W. Dekker, et al.. (1997). Quality of Life in Patients with Graves' Ophthalmopathy is Markedly Decreased: Measurement by the Medical Outcomes Study Instrument. Thyroid. 7(6). 885–889. 164 indexed citations

14.

Prummel, Mark F., Wilmar M. Wiersinga, Hans Oosting, & E Endert. (1996). The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-I. Journal of Endocrinological Investigation. 19(9). 620–623. 26 indexed citations

15.

Portolano, S, Mark F. Prummel, Basil Rapoport, & Sandra M. McLachlan. (1995). Molecular cloning and characterization of human thyroid peroxidase autoantibodies of lambda light chain type. Molecular Immunology. 32(14-15). 1157–1169. 26 indexed citations

16.

Prummel, Mark F., Arie Berghout, Wilmar M. Wiersinga, et al.. (1993). Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. The Lancet. 342(8877). 949–954. 235 indexed citations

17.

Pouw, E.M., Mark F. Prummel, Hans Oosting, Carolyn M Roos, & Erik Endert. (1991). Beclomethasone inhalation decreases serum osteocalcin concentrations.. BMJ. 302(6777). 627–628. 132 indexed citations

18.

Prummel, Mark F., et al.. (1991). Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan. Journal of Internal Medicine. 229(6). 545–548. 12 indexed citations

19.

Gaag, R. van der, Wilmar M. Wiersinga, Leo Koornneef, et al.. (1990). HLA-DR4 associated response to corticosteroids in Graves’ ophthalmopathy patients. Journal of Endocrinological Investigation. 13(6). 489–492. 4 indexed citations

20.

Henny, Ch. P., Hugo Ten Cate, J W ten Cate, et al.. (1986). Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid. Thrombosis and Haemostasis. 55(2). 301–301. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact